[Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
Alhadad
Alaa
A
alaa.alhadad@skane.se
Wiktorsson
Catarina
C
Lindblad
Bengt
B
Gottsäter
Anders
A
D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011182:Postoperative Care; D012042:Registries; D012307:Risk Factors; D055502:Secondary Prevention; D016540:Smoking Cessation; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors